Regeneron shares fall 12% on disappointing melanoma trial data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Regeneron (NASDAQ: REGN) | Delayed: 805.02 -14.07 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $819.09 | 52 Week High | $592.36 | |||
| Open | $819.09 | 52 Week Low | $325.35 | |||
| Day High | $819.09 | P/E | 211.29 | |||
| Day Low | $801.22 | EPS | $3.81 | |||
| Volume | 526,650 | |||||
